Inclusion Criteria:
  -  Patients met diagnostic criteria for schizophrenia or schizoaffective disorder using the Structural Clinical Interview for Diagnostic and Statistical Manual Diploma in Social Medicine (DSM)-IV (SCID, Version 2.0).
  -  Patients remain their psychotropic medication at steady dosages for at least 4 weeks prior to study entry and for the duration of the trial.
  -  Verbal intelligence quotient > 85 as measured by using a Chinese version of the National Adult Reading Test.
Exclusion Criteria:
  -  History of significant head trauma or neurological disorders
  -  Alcohol or drug abuse Focal brain lesions on T1- or T2-weighted fluid-attenuated inversion-recovery magnetic resonance images
  -  a prior history of a seizure not induced by drug withdrawal,first degree relative with epilepsy, significant neurological illness or head trauma, endocrine disease, such as thyroid disease, significant unstable medical condition, recent aggression or other forms of behavioral dyscontrol
  -  left-handedness, pregnancy
  -  estimated intelligence quotient<80
  -  current alcohol or drug abuse
  -  inability to provide informed consent.
  -  Hamilton Anxiety Rating Scale or the Hamilton Depression Rating Scale score > 10